Celanese(US:CE) Globenewswire·2025-09-24 20:10Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices by Celanese Corporation and its officers or directors, following disappointing financial results and significant stock price declines [1][4][5]. Financial Performance - In Q3 2024, Celanese reported adjusted earnings of $2.44 per share, below the consensus estimate of $2.84, and revenue of $2.65 billion, a 2.6% year-over-year decline, also missing the consensus estimate of $2.69 billion [3]. - For the full year 2024, Celanese reported a U.S. GAAP diluted loss per share of $13.86 and adjusted earnings per share of $8.37, with net sales of $10.3 billion, a 6% decrease from the previous year due to a 4% decline in price and a 1% decline in volume [4]. - In Q2 2025, Celanese's Engineered Materials segment continued to experience below-normal volumes due to destocking in Europe, leading to further disappointing financial results [5]. Stock Price Reaction - Following the Q3 2024 results, Celanese's stock price fell by $32.50, or 26.32%, closing at $91.00 on November 5, 2024 [3]. - After the Q4 and full year 2024 results, the stock price dropped by $15.00, or 21.46%, closing at $54.91 on February 19, 2025 [4]. - On August 12, 2025, the stock price fell by $6.20, or 13.07%, closing at $41.22 due to ongoing issues in the Engineered Materials segment [5].